Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
59.6% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
24
users have liked this narrative
6
users have commented on this narrative
54
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
31
users have liked this narrative
6
users have commented on this narrative
87
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.8% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Space42
AL
ALPHA_AD1
Community Contributor
🚀 “Mission to Momentum: Why Space42’s True Orbit Is AED 6.43”
Narrative Valuation Summary Space42 is not your average growth story—it's a digital infrastructure powerhouse executing a high-velocity scale-up strategy. With a projected annual revenue growth of 67.8% , the company is expanding aggressively across digital platforms, cloud analytics, and AI-driven enterprise services.
View narrative
د.إ6.43
FV
66.7% undervalued
intrinsic discount
67.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
4
users have followed this narrative
2 months ago
author updated this narrative
2298
Cosmo Lady (China) Holdings
VA
Valar_Morghulis
Community Contributor
Cosmo Lady (China) Holdings will face challenges with a projected fair value of 0.18
创始人重新执掌公司,总是最正面的故事起点,发生在2021年。这并不容易,反映到经营成果上表,已经花费了3年时间。 现在按困境反转,买进一个观察仓位。30亿销售额当成再次出发的起点。当前6倍PE是行业最低估值的公司之一,先回归到行业均值,或1倍PB,0.98元。
View narrative
HK$0.98
FV
61.2% undervalued
intrinsic discount
32.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
12 days ago
author updated this narrative
Creades
NA
Navve64
Community Contributor
Creades set to thrive with a 91.9% profit margin boost
Valuation Where do you think the business will be in 3, 5 or 10 years time? What do you think revenue and profit margins will be?
View narrative
SEK 85.00
FV
7.3% undervalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Intel
MS
mschoen25
Community Contributor
Strong competition - needs time to recover
tel Corporation (INTC) might be considered undervalued for several reasons, depending on the perspective of investors and analysts. Some potential reasons include: Market Sentiment and Competition : Intel has faced increased competition from companies like AMD and NVIDIA, which have eaten into its market share, particularly in CPUs and GPUs. This has led to negative market sentiment despite Intel’s continued dominance in certain sectors, such as data centers.
View narrative
US$36.54
FV
45.8% undervalued
intrinsic discount
3.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
13 days ago
author updated this narrative
Eastman Chemical
DE
DerpOtron9k
Community Contributor
Eastman Chemical (EMN) offers a compelling balance for long-term dividend investors
EMN – Eastman Chemical Company 1. Reliable & Growing Dividend - EMN has increased its dividend for 16 consecutive years.
View narrative
US$67.68
FV
9.5% undervalued
intrinsic discount
9.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 2 months ago
author updated this narrative
Target
AS
AscendedInvestor
Community Contributor
(Hold) Borderline Buy
Possible A.I driven and efficiency profit margin gains could send stock higher. D.E.I boycotts will falter.
View narrative
US$123.63
FV
14.5% undervalued
intrinsic discount
3.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
18 days ago
author updated this narrative
Porsche Automobil Holding
ST
StefanoF
Community Contributor
Is Porsche Automobil Holding set to surpass analyst targets with fair value at €40
Based on my research, here's a brief fundamental analysis and DCF valuation of Porsche Automobil Holding SE (PAH3): Fundamental Analysis Business Model: Porsche SE is a holding company that owns 52.2% of Volkswagen AG (including 12 brands: Audi, Bentley, Bugatti, Ducati, Lamborghini, MAN, Porsche, Scania, SEAT, ŠKODA, Volkswagen Commercial Vehicles and Volkswagen Passenger Cars) and has investments in mobility and industrial technology 2024 Financial Performance: Profit after tax: €2.51 billion (9M 2024), down 34% YoY from €3.8 billion 2024 full-year profit forecast: €2.4-4.4 billion range Net debt projected: €5.0-5.5 billion by year-end 2024 2024 dividend: €1.910 per preferred share, €1.904 per ordinary share Key Challenges: Expected significant non-cash impairment losses on VW and Porsche AG investments for 2024, making group result after tax significantly negative Trading at 29.8% discount to NAV Heavy reliance on dividends from VW and Porsche AG for debt servicing DCF Valuation Current Market Data: Current stock price: €36.77 (as of April 28, 2025) Analyst average price target: €45.78 (range: €35-78) DCF Analysis: PAH3's DCF value cannot be reliably calculated due to the holding company structure and irregular cash flow patterns. However, alternative valuation approaches suggest: Intrinsic value estimate: $6.849 USD (€6.40 approx.) - shows 26% undervaluation based on multiples-only approach Analyst consensus implies 31.74% upside potential to €45.78 Investment Thesis: Strengths: Exposure to leading automotive brands, solid dividend history, trading at discount to NAV Risks: High leverage (€5.3B net debt), impairment charges, dependence on underlying holdings' performance Conclusion: PAH3 appears undervalued at current levels, but traditional DCF valuation is challenging due to its holding company structure.
View narrative
€40.00
FV
12.0% undervalued
intrinsic discount
0%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
2 months ago
author updated this narrative
Cerro de Pasco Resources
AG
Agricola
Community Contributor
A CASE FOR USD$2.50 (CAD$3.44) BY 2028 (A 5-10 BAGGER)
Projection for December 2028, Assuming Silver at USD 100, Oil at USD 50/Barrel, Gallium Prices Stable, and All Production Goals Achieved Company Overview Cerro de Pasco Resources Inc. (TSXV:CDPR) is a Canadian junior mining company focused on silver, zinc, and lead exploration and development, primarily through its El Metalurgista concession in Peru.
View narrative
CA$3.44
FV
85.6% undervalued
intrinsic discount
105.46%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
4
users have commented on this narrative
32
users have followed this narrative
2 months ago
author updated this narrative
Laboratorios Farmaceuticos Rovi
KA
kapirey
Community Contributor
The future of Rovi is very uncertain, we must wait until the year 2026 to have a clear projection.
Recent Financial Performance In H1 2025, Rovi’s net profit dropped by 10% to €39.7 million. The decline was mainly due to reduced third-party manufacturing, especially COVID-19 vaccine production.
View narrative
€51.25
FV
3.6% overvalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
12 days ago
author updated this narrative
Value any company in seconds
Popular companies